Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The newer orforglipron (Foundayo) pill comes in doses of 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg
Hormones 14(1):8190
Access options Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Learn more Rent or buy this article Prices vary by article type from$1.95 to$39.95 Learn more Prices may be subject to local taxes which are calculated during checkout Nature 638 , 591-592 (2025) doi: Reprints and permissions Subjects Obesity Drug discovery Latest on: Obesity Drug discovery The latest benefit of obesity drugs: boosting testosterone and sperm quality News Obesity doesnt equate to ill health: why the disease label doesnt always fit Comment A deep-learning framework reveals whole-body perturbations at cell level Article New hope in the fight against cachexia cancers deadly co-conspirator News Feature Could this mysterious disappearing organ hold the key to longevity
Semaglutide works for weight loss by mimicking the action of incretin, a natural gut hormone called GLP-1, and targeting GLP-1 receptors in the brain that control appetite and slow down how quickly the stomach empties, making you feel fuller for longer
FAQ Section What is BPC-157, and how does it work
NICE recommends cognitive behavioural therapy (CBT-ED) as first-line treatment for binge eating disorder, not medication alone
